Del. Judge Outlines Misconduct Behind Amgen's $50M Relief
A Delaware federal judge on Wednesday overruled German biotech company Lindis's $50 million patent infringement win against Amgen, finding an inventor purposefully withheld harmful information from the U.S. Patent and Trademark...To view the full article, register now.
Already a subscriber? Click here to view full article